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ABSTRACT 
Amaranthus dubius is known for its various remedies against many ill conditions. Present study has been carried out to delayed type 
hypersensitivity reaction also stimulated by Amaranthus dubius significantly indicates that the extract could stimulate the haemopoetic system. 
The mechanism of action could be unfolded only after detailed investigations whereby the extract modulates the immune system however; the 
extract contains compounds which had immunomodulatory activity. CMI responses are critical to defence against infectious organisms, 
infection of foreign grafts, tumor immunity and delayed‐type hypersensitivity reactions. Therefore, increase in DTH reaction in rat in response 
to T cell dependent antigen revealed the stimulatory effect by pretreatment of levamisole on T cell. DTH is a part of the process of graft 
rejection, tumour immunity, and, most important, immunity to many intracellular infectious microorganisms, especially those causing chronic 
diseases. 
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INTRODUCTION 
Immunology is the study of the methods by which the body 
defends itself from infectious agents and other foreign 
substances in its environment1. An infectious organism that 
causes a disease is called a pathogen and the individual 
(person or animal) that is infected by a pathogen is called 
the host. There are thousands of components to the immune 
system and it would appear that the immune system is far 
more complicated than necessary for achieving what is, on 
the surface, a simple task of eliminating a pathogenic 
organism or abnormal ‘self’ cells2.  
However there are a number of reasons for this complexity, 
including the desirability of eliminating pathogens without 
causing damage to the host. Getting rid of a pathogen or 
dead host cells is theoretically easy, but eliminating these 
without damaging the host is much more complicated. As a 
consequence of this dynamic complexity, the immune 
system is able to generate a tremendous variety of cells and 
molecules capable of specifically recognizing and eliminating 
an apparently limitless variety of foreign invaders, in 
addition to the recognition and destruction of abnormal 
cells3. Once a foreign protein, microorganism (e.g., 
bacterium, fungus or virus) or abnormal cell is recognized, 
the immune system enlists the participation of a variety of 
cells and molecules to mount an appropriate effector 
response to eliminate or neutralize them4. Later exposure to 
the same foreign organism induces a memory response, 
characterized by a heightened immune reactivity, which 
serves to eliminate the microbial pathogen, prevent disease 
and protect against the development of some tumour cells.  
Amaranthus dubius Linn. (Family: Amaranthaceae) is 
commonly known as spiny amaranth, prickly amaranth or 
thorny amaranth. It is widely distributed throughout the 
tropics and warm temperate regions of Asia as a weed in 
cultivated as well as fallow lands5. In India, it is commonly 
known as ‘‘Kate Wali Chaulai (Kanatabhajii)” and used as 
vegetable and cultivated throughout India. It is widely used 
in folk lore medicinal system of India. The whole plant and 
parts of the plant contains medicinally active constituents 
such as alkaloids, flavonoids, glycosides, phenolic acids, 
steroids, amino acids, terpenoids, lipids, saponins, betalains, 
b-sitosterol, stigmasterol, linoleicacid, rutin, catechuic 
tannins and carotenoids6. Extracts of A. spinosus have been 
reported to show diuretic, antidiabetic, antipyretic, anti-
snake venom, antileprotic, anti-gonorrheal antioxidant, anti-
cholesterolemic, antipyretic, anti-inflammatory, 
spermatogenic, antitumor, antifertility, anti-malarial, 
hepatoprotective activities7-10 and also effects on 
hematology and biochemical changes in the epididymis11. 
Thus, we reported in present study; phytochemical and 
evaluation of immunomodulatory potential of Amaranthus 
dubius leaf on rodent models. 
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MATERIALS & METHODS  
Plant Material  
A. dubius as a whole plant was collected from in and around 
places of Bhopal district in Madhya Pradesh state and 
identified in Department of Botany of Safia College.  
Extraction preparation  
Whole plant was air dried under shaded conditions and 
coarsely powdered. Hundred gram of powder was refluxed 
with 600 ml of water at 100oC for 24 hours. The extract was 
filtered through double layer 100 µm nylon wire mesh and 
concentrated at 50oC to obtain crude aqueous extract. 
Experimental Animals 
Normal healthy male Wistar rats (Rattus norvegicus) 
weighing 200-240g were used in the present investigation. 
The animals were maintained as per the guidelines for care 
and use of Animals for Scientific Research proposed by 
Indian National Science Academy, 2000 at Department of 
Zoology, in group of three animals in polypropylene rat 
cages under 12:12 hrs. Light-dark schedule and fed with rat 
pellet diet and water was provided ad libitum. 
Experimental Design  
The animals were divided into four group viz. Group I, Group 
II, Group III and Group IV, consisting 10 animals in each 
group. The aqueous extract of A. spinosus was administered 
orally at 125, 250, 500 and 1000 mg/Kg body wt. /day 
respectively for 60 days. Control animals were administered 
with distilled water. Following completion of respective 
treatment schedule, all the animals were withdrawn from 
the treatment for a further period up to 90 days. Five 
animals from each group were sacrificed the next day 
following the 60th day of treatment and remaining five after 
90 days of treatment withdrawal. 
Acute Toxicity and Lethality:  
Investigation on acute toxicity of the extract with estimation 
of the median lethal dose (LD50) was carried out using 
Lorke’s method (1983). Thirteen experimental animals 
(mice with weight range of 20g-30g) were used for the test. 
In the investigation, three groups of mice containing three 
mice each were administered 10-, 100- and 1000g/kg 
respectively of the aqueous extract intraperitoneally (ip). 
They were observed closely for 24 hr for lethality or any 
other behavioral response. Based on the result, further 
increased doses of 1500-, 2000-, 3000- and 5000 mg/kg 
were administered ip to four other mice respectively. They 
were also observed for 24 hr for any death or behavioural 
changes.  
Experimental Design  
A total of fifty (50) Wistar albino rats used in Delayed Type 
Hypersensitivity Reaction and Humoural Antibody titre 
(twenty five (25) rats for each parameter) were grouped as 
follows: 
Group A: Rats were treated with SRBC and normal saline and 
it served as control  
Group B: Rats were treated with SRBC and 50 mg/kg body 
weight of extract  
Group C: Rats were treated with SRBC and 100 mg/kg body 
weight of extract  
Group D: Rats were treated with SRBC and 250 mg/kg body 
weight of extract  
Group E: Rats were treated with SRBC and 25 mg/kg body 
weight of levamisol  
Immunomodulatory Activity of Extracts  
Preparation of Antigen:  
Fresh sheep blood was obtained from the animal farm of the 
Faculty of Veterinary Medicine, Sheep red blood cells 
(SRBCs) were washed three times in continous volume of 
pyrogen-free sterile normal saline by centrifugation at 
3000×g for 10 min on each occasion. The washed SRBCs 
were adjusted to a concentration of 109cells/ml for 
immunization and challenge.  
Delayed Type Hypersensitivity (DTH) Reaction  
Delayed type hypersensitivity (DTH) reaction was 
investigated using the method of Navedet al. (2005). DTH 
reaction was induced in rats using SRBCs as antigen. Animals 
were sensitized by subcutaneous injection of 0.02 ml of 
109cells/ml SRBCs (day 0) in the plantar region of right hind 
foot paw and challenged on day 5 by subcutaneous injection 
of the same amount of antigen into the left hind paw. The 
oedema produced by antigenic challenge in the left hind paw 
was measured as the difference in the paw thickness before 
challenge; 24 hr and 48 hr after the challenge. The paw 
thickness was measured with a pocket-sized screw guage12. 
The extracts were administered three days prior to 
sensitization and continued daily till the challenge.  
Humoural Antibody (HA) Synthesis  
Rats were immunized by an intraperitoneal injection (i.p) of 
0.1ml of 109 SRBC ml-1 on day 0 and challenged by similar ip 
injection of the same amount of 0.1 ml on day 5. Primary 
antibody titre was determined on day 5 (before the 
challenge) and secondary titre on day 10 (Sharma et al., 
1996) by haemagglutination technique13. The aqueous 
extract (50, 100 and 250 mgKg-1) was administered 3 days 
prior to immunization and continued daily for 5 days after 
challenge. Blood samples were obtained by retro-orbital 
puncture and collected in a test tube and allowed to clot. For 
each sample, a 25μL serum was obtained after centrifugation 
and serially diluted two-fold in 96-U well microtitre plates 
using pyrogen-free sterile normal saline as control. The 
diluted sera were challenged with 25μL of 1% (v/v) SRBC in 
the plates and then incubated at 370C for 1hr. The highest 
dilution giving rise to visible haemagglutination was taken 
and antibody titre expressed in graded manner, the 
minimum dilution (1/2) being ranked as 1 (calculated as 
Log2 of the dilution factor). The mean ranks of different 
treatment groups were compared for statistical significance. 
RESULTS AND DISCUSSION 
Effect of Extract on Humoural Immunity  
Fig. 1 below reveals the effect of the extract on humoural 
immune response which was assessed using humoural 
antibody titre. The result indicates that there was 
augmentation of the humoural immune response to SRBCs 
by the extract and levamisol which was evidenced by the 
increase in the antibody titre. It also reveals that as the 
number of pretreatment days increased, the primary and 
secondary antibody increased in the rat. Both the primary 
and secondary antibody titre induced a significant rise (p < 
0.05) in the antibody titre when compared to the control A. 
Administration of the extract produced dose dependent 
increase in humoural antibody titre. It is also obvious from 
the figure that the effect of 250mg/kg of extract was more 
than that of levamisol solution. 
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Fig. 1: Effect of A. dubius on primary and secondary antibody titre. 
The values are expressed as (Mean ± SD) n=5 per group p < 0.05  
Group A = Rats treated with SRBC and normal saline and it served as the control  
Group B = Rats treated with SRBC and 50 mg/kg body weight of extract  
Group C = Rats treated with SRBC and 100 mg/kg body weight of extract  
Group D = Rats treated with SRBC and 250 mg/kg body weight of extract  
Group E = Rats treated with SRBC and 500 mg/kg body weight of extract  
Effect of extract on Cell Mediated Immunity  
Fig. 2 shows the induction of DTH reaction induced in the 
hind foot paw of rats using SRBC and DTH response checked 
by increased footpad thickness using vernier calliper. The 
challenged rat elicited a significant increase (p < 0.05) in 
thickness of footpad 24 hr and 48 hr after challenge. 
Administration of 50, 100 and 250 mg/kg of extract 
produced a dose and time dependent increase in footpad 
swelling of the rats.  
At 24 hr after challenge, it is evident that the extract doses of 
50, 100 and 250 mg/kg and 25 mg/kg body weight of 
levamisol significantly boosted (p < 0.05) DTH reactions 
observed as 1.412, 1.504, 1.816 and 1.827 mm difference 
respectively in thickness of footpad before challenge and 24 
hr after challenge. In group A serving as the control, there 
was a non-insignificant increase (p < 0.05) with a difference 
of 0.614 mm in the thickness of footpad before challenge and 
24 hr after challenge. 
At 48 hr after challenge, Fig. 2 also shows an additional 
increase in footpad swelling of rats in groups B, C D and E 
observed as 1.908, 1.918, 2.304 and 2.326 mm respectively. 
This reveals that at 48 hr after challenge, the extract and 
levamisol still had stimulatory effect on T lymphocyte and 
accessory cell types required for expression of DTH reaction. 
 
 
Fig. 2: Effect of A. dubius treatment on cell mediated immune response by DTH induced footpad oedema. 
The values are expressed as (Mean ± SD) n=5 per group p < 0.05.  
Group A = Rats treated with SRBC and normal saline and it served as control  
Group B = Rats treated with SRBC and 50 mg/kg body weight of extract  
Group C = Rats treated with SRBC and 100 mg/kg body weight of extract  
Group D = Rats treated with SRBC and 250 mg/kg body weight of extract  
Group E = Rats treated with SRBC and 500 mg/kg body weight of extract  
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IV. DISCUSSION  
Immunomodulation is a procedure which can alter the 
immune system of an organism by interfering with its 
functions; if it results in an enhancement of immune 
reactions it is named as an immune-stimulative drug which 
primarily implies stimulation of specific and nonspecific 
system, i.e. granulocytes, macrophages, complement, certain 
T-lymphocytes and different effector substances. Immuno-
suppression implies mainly to reduce resistance against 
infections and stress and it may occur on account of 
environmental or chemotherapeutic factor. The results 
obtained in the present study indicate that aqueous extract 
of A. dubius is a potent immune-stimulant, stimulating 
specific and non-specific immune mechanisms. To evaluate 
the effect of aqueous extract of A. dubius on humoural 
response, its influence was tested on sheep erythrocyte 
specific Ab titre in rats. From the results obtained in the 
present study and shown in Fig. 1 above, there was increase 
in humoural immune response to SRBCs as evidenced by 
increase in antibody titre. This indicates that aqueous 
extract of A. dubius is a potent immunostimulant, with the 
ability to stimulate specific and non-specific immune 
mechanisms. This suggests that the extract might have the 
ability of enhancing the interaction of B cells with the 
antigen and subsequent proliferation and differentiation of 
B-lymphocytes into antibody-secreting plasma cells. The 
antibody produced by the activated plasma cell then 
inactivates the antigen by complement fixation where 
proteins attach to antigen surface and causes holes to form 
leading to cell lysis; by neutralization where the Ab binds to 
specific site preventing antigen attachment; by agglutination 
which involves clumping together of the Ag inactivating 
them; by precipitation whereby insolubility is forced and the 
antigen settles out of solution. Moreover, the extract might 
be able to activate lymphoid dendritic cell which stimulate 
lower amounts of IL-12 and higher amounts of IFN-α which 
primarily elicit Th2 development. Activated Th2 cell 
stimulate Ab production by secreting IL-4 which proliferates 
B-cell to plasma cell. Activated Th2 also releases cytokines 
such as IL-2, IL-4 and IL-10 which activates mast cells 
leading to the production of serotonin and histamine, 
mediators of inflammatory response. 
The ability of the extract to induce primary Ab titre shows 
that it may stimulate IgM which is the major Ab present in 
the body during primary immune response. IgM is effective 
in activating the complement components which facilitate 
the phagocytosis of pathogens by macrophages. 
Furthermore, the result also showed that the extract 
significantly increased (p < 0.05) secondary Ab titre 
suggesting that on re-exposure to the same Ag, the extract 
was able to accelerate secondary response and enhance the 
production of IgG. IgG and IgM are the major 
immunoglobulins which are involved in the complement 
activation, opsonization, and neutralization of toxins. The 
stimulation of immunoglobulin by the extract suggests that it 
activates IgA and lactoferrin the major immunoprotein 
present in breast milk and which confers immunity to the 
neonate. The augmentation of the humoural responsiveness 
to SRBC in rats as consequence of both pre and post 
immunization treatment with levamisol corresponds with 
the report of Lai et al., (2002) who reported levamisol 
improved immunitary defences by its interferon-like activity 
and by restoring Th cell activity; evoking maturation of 
thermocytes; increasing the metabolic activity of blood 
monocytes and their affinity for the Fc fragment of IgG. Cell-
mediated immunity (CMI) involves effector mechanisms 
carried out by T lymphocytes and their products 
(lymphokines). DTH is a Type IV hypersensitivity reaction 
that develops when antigen activates sensitized TDTH cells. 
DTH response was checked by increased footpad thickness 
using verniercaliper. The animals treated with levamisol and 
extracts showed a significant (p < 0.05) change in DTH 
response as compared to control animals. As can be evident 
from (Fig. 2), a significant (P < 0.05) increase in DTH 
response was observed at the doses: 50, 100 and 250 mg/kg 
dose of Senna extract and levamisol 25 mg/kg. Therefore, 
increase in DTH reaction in rats in response to T cell 
dependent antigen revealed the stimulatory effect of 
aqueous extract of Senna on T cells. The result shown above 
suggests that during the first stage of the DTH response 
known as sensitization stage, the extract might have 
activated Th1 cells and also expanded clonally APCs with 
class II MHC. Then the protein of the antigen (in this case 
SRBC) will be presented at the external wall of the APC in a 
changed MHC class II, to chemotactically attract naive proT-
lymphocyte known as Th0. The Ag-peptide will be taken 
from the MHC of the APC and bound to T-cell receptor 
activating the Th0 cell converting it to Th1 cell. Th1 cell then 
commences the effector phase of the DTH response. 
Moreover, the activated Th1 which may have been enhanced 
by the extract, proliferates and releases cytokines (IL-2, IL-
12, IL-18, IFN-γ, TNF-α) which increases vascular 
permeability, induces vasodilation, activates and 
accumulates macrophages and NK cells and all these 
promotes increased phagocytic activity and increased 
concentration of lytic enzymes. The probable stimulation of 
Th1 cell by the extract also suggest that the NK cell which 
was subsequently stimulated used a protein named 
perfrorin to destroy the SRBC by inoculating the protein into 
the antigen (in this case SRBC) cell membrane. This perforin 
molecule then assembles in the membrane to form a pore, 
through which other molecules can flow into the target. 
Moreover, it also produces IFN which are powerful 
activators of macrophages. Treatment with the aqueous 
extract of Senna enhanced DTH reaction, which is reflected 
from the increased footpad thickness compared to control 
group suggesting heightened infiltration of macrophages to 
the inflammatory site. The probable mechanism of action of 
the extract might be by activating myeloid dendritic cells 
which are known to also produce a large amount of IL-12 
and preferentially induce Th1 development. The extract 
might be immunogenic by activating complement which 
recruit and stimulate cellular elements of the immune 
system, such as histamine, basophils, macrophages, within 
24-72 hr initiating inflammatory reactions and phagocytosis 
of pathogens which lead to increase in the rat paw oedema 
as depicted in Fig 2 above. Increase in the DTH response 
indicates that drug has a stimulatory effect on lymphocytes 
and necessary cell types required for the expression 
reaction. As shown in fig. 2 above, DTH response, which is 
direct co-related to cell-mediated immunity, was 
significantly increased (p < 0.05) with aqueous extract of 
Senna extract as compared to untreated control. There are 
some plants like Aesculusindica, Argyreiaspeciosa which are 
reported for acting on delayed type of hypersensitivity. The 
increase in rat paw oedema of rats treated with levamisol as 
shown in the Fig above corresponds with former reports of 
Yadavet al., (2011) showing the stimulatory effect of 
levamisol on lymphocytes and other cell types. Lai et al., 
(2002) reported that levamisol improved DTH in 
immunodepressed individuals to restore Th and Ts cell 
activity and also increases their activity. 
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